TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF THE GLOBAL MEDICAL AESTHETICS MARKET 16
1.4 LIMITATIONS 18
1.5 MARKETS COVERED 18
2 MARKET SEGMENTATION 21
2.1 MARKETS COVERED 21
2.2 GEOGRAPHICAL SCOPE 22
2.3 YEARS CONSIDERED FOR THE STUDY 23
2.4 CURRENCY AND PRICING 23
2.5 DBMR TRIPOD DATA VALIDATION MODEL 24
2.6 MULTIVARIATE MODELLING 27
2.7 PRODUCT TYPE LIFELINE CURVE 27
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.9 DBMR MARKET POSITION GRID 29
2.10 MARKET APPLICATION COVERAGE GRID 30
2.11 SECONDARY SOURCES 31
2.12 ASSUMPTIONS 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 35
4.1 PORTERS FIVE FORCES 38
4.2 PESTEL ANALYSIS 39
4.3 CUSTOMISED DATA: 40
4.3.1 INTRODUCTION 40
5 GLOBAL MEDICAL AESTHETICS MARKET, REGULATIONS 47
6 MARKET OVERVIEW 51
6.1 DRIVERS 53
6.1.1 AGING POPULATION GLOBALLY 53
6.1.2 TECHNOLOGICAL ADVANCEMENTS 53
6.1.3 KEY PLAYERS ARE TAKING STRATEGIC DECISIONS TO GAIN MARKET SHARE 54
6.2 RESTRAINTS 54
6.2.1 STRINGENT REGULATORY POLICIES 54
6.2.2 HIGH COST FOR THE TREATMENTS. 55
6.3 OPPORTUNITIES 55
6.3.1 IMMENT HEALTH REVOLUTION 55
6.3.2 GROWING MEDICAL TOURISM IN ASIA 56
6.4 CHALLENGE 57
6.4.1 INCREASING COMPETITORS 57
7 GLOBAL MEDICAL AESTHETICS MARKET, BY PRODUCT TYPE 58
7.1 OVERVIEW 59
7.2 AESTHETIC LASER DEVICES 62
7.2.1 ABLATIVE SKIN RESURFACING DEVICES 63
7.2.1.1 CO2 LASER 63
7.2.1.2 ERBIUM LASER 63
7.2.1.3 OTHERS 63
7.2.2 NON-ABLATIVE FRACTIONAL LASER RESURFACING DEVICES 63
7.2.2.1 RADIOFREQUENCY 64
7.2.2.2 INTENSE PULSED LIGHT 64
7.2.2.3 FRACTIONAL LASER 64
7.2.2.4 THE Q-SWITCHED ND:YAG LASER 64
7.2.2.5 OTHERS 64
7.3 ENERGY DEVICES 64
7.3.1 LASER SURGERY DEVICES 65
7.3.2 ELECTROCAUTERY DEVICES 65
7.3.3 ELECTROSURGERY DEVICES 65
7.3.4 CRYOSURGERY DEVICES 66
7.3.5 HARMONIC SCALPEL 66
7.3.6 MICROWAVE DEVICES 66
7.4 BODY CONTOURING DEVICES 66
7.4.1 LIPOSUCTION 67
7.4.2 NONSURGICAL SKIN TIGHTENING 67
7.4.3 CELLULITE TREATMENT 67
7.5 FACIAL AESTHETIC DEVICES 67
7.5.1 BOTOX INJECTION 68
7.5.2 DERMAL FILLERS 68
7.5.2.1 NATURAL DERMAL FILLERS 69
7.5.2.2 SYNTHETIC DERMAL FILLERS 69
7.5.3 COLLAGEN INJECTIONS 69
7.5.4 CHEMICAL PEEL 69
7.5.5 FACIAL TONING 69
7.5.6 FRAXEL 69
7.5.7 COSMETIC ACUPUNCTURE 69
7.5.8 ELECTROTHERAPY 69
7.5.9 MICRODERMABRASION 69
7.5.10 PERMANENT MAKEUP 70
7.6 AESTHETIC IMPLANTS 70
7.6.1 BREAST AUGMENTATION 71
7.6.1.1 SALINE IMPLANTS 71
7.6.1.2 SILICON IMPLANTS 71
7.6.2 BUTTOCK AUGMENTATION 71
7.6.3 AESTHETIC DENTAL IMPLANTS 72
7.6.3.1 DENTAL TITANIUM IMPLANTS 72
7.6.3.2 DENTAL ZERCONIUM IMPLANTS 72
7.6.4 FACIAL IMPLANTS 72
7.6.5 SOFT TISSUE IMPLANTS 72
7.6.6 TRANSDERMAL IMPLANT 72
7.6.7 OTHERS 72
7.7 SKIN AESTHETIC DEVICES 73
7.7.1 LASER SKIN RESURFACING DEVICES 74
7.7.2 NON SURGICAL SKIN TIGHTENING DEVICES 74
7.7.3 LIGHT THERAPY DEVICES 74
7.7.4 TATTOO REMOVAL DEVICES 74
7.7.5 MICRO-NEEDLING PRODUCTS 75
7.7.6 THREAD LIFT PRODUCTS 75
7.7.7 NAIL TREATMENT LASER DEVICES 75
7.7.8 OTHERS 75
8 GLOBAL MEDICAL AESTHETICS MARKET, BY APPLICATION 76
8.1 OVERVIEW 77
8.2 ANTI-AGING AND WRINKLES 81
8.3 FACIAL AND SKIN REJUVENATION 81
8.4 BREAST ENHANCEMENT 82
8.5 BODY SHAPING AND CELLULITE 83
8.6 TATTOO REMOVAL 83
8.7 VASCULAR LESIONS 84
8.7.1 SEARS, PIGMENT LESIONS, RECONSTRUCTIVE 84
8.8 PSORIASIS AND VITILIGO 85
8.9 OTHERS 86
9 GLOBAL MEDICAL AESTHETICS MARKET, BY END USER 87
9.1 OVERVIEW 88
9.2 COSMETIC CENTERS 91
9.3 DERMATOLOGY CLINICS 91
9.4 HOSPITALS 92
9.5 MEDICAL SPAS AND BEAUTY CENTERS 92
10 GLOBAL MEDICAL AESTHETICS MARKET, BY DISTRIBUTION CHANNEL 93
10.1 OVERVIEW 94
10.2 DIRECT TENDER 96
10.3 RETAIL 97
11 GLOBAL MEDICAL AESTHETIC DEVICES MARKET, BY REGION 98
11.1 OVERVIEW 99
11.2 NORTH AMERICA 104
11.2.1 U.S. 108
11.2.2 CANADA 108
11.2.3 MEXICO 108
11.3 EUROPE 109
11.3.1 GERMANY 113
11.3.2 U.K. 113
11.3.3 FRANCE 113
11.3.4 ITALY 113
11.3.5 SPAIN 113
11.3.6 RUSSIA 113
11.3.7 NETHERLANDS 113
11.3.8 SWITZERLAND 113
11.3.9 BELGIUM 113
11.3.10 TURKEY 113
11.3.11 REST OF EUROPE 113
11.4 ASIA PACIFIC 114
11.4.1 CHINA 118
11.4.2 INDIA 118
11.4.3 JAPAN 118
11.4.4 SOUTH KOREA 118
11.4.5 SINGAPORE 118
11.4.6 THAILAND 118
11.4.7 MALAYSIA 118
11.4.8 INDONESIA 118
11.4.9 AUSTRALIA 118
11.4.10 PHILIPPINES 118
11.4.11 REST OF ASIA-PACIFIC 118
11.5 SOUTH AMERICA 119
11.5.1 BRAZIL 123
11.5.2 ARGENTINA 123
11.5.3 REST OF SOUTH AMERICA 123
11.6 MIDDLE EAST AND AFRICA 124
11.6.1 SOUTH AFRICA 128
11.6.2 U.A.E. 128
11.6.3 SAUDI ARABIA 128
11.6.4 REST OF MIDDLE EAST AND AFRICA 128
12 GLOBAL MEDICAL AESTHETICS MARKET: COMPANY LANDSCAPE 129
12.1 COMPANY SHARE ANALYSIS: GLOBAL 129
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 130
12.3 COMPANY SHARE ANALYSIS: EUROPE 131
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 132
13 COMPANY PROFILE 133
13.1 ALLERGAN 133
13.1.1 COMPANY SNAPSHOT 133
13.1.2 SWOT ANALYSIS 134
13.1.3 REVENUE ANALYSIS 135
13.1.4 COMPANY SHARE ANALYSIS 135
13.1.5 PRODUCT PORTFOLIO 136
13.1.6 RECENT DEVELOPMENTS 136
13.1.7 DATA BRIDGE MARKET RESEARCH ANALYSIS 137
13.2 BAUSCH HEALTH COMPANIES INC. 138
13.2.1 COMPANY SNAPSHOT 138
13.2.2 SWOT ANALYSIS 139
13.2.3 REVENUE ANALYSIS 140
13.2.4 PRODUCT PORTFOLIO 140
13.2.5 RECENT DEVELOPMENTS 141
13.2.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 141
13.3 LUMENIS 142
13.3.1 COMPANY SNAPSHOT 142
13.3.2 SWOT ANALYSIS 143
13.3.3 COMPANY SHARE ANALYSIS 144
13.3.4 PRODUCT PORTFOLIO 144
13.3.5 RECENT DEVELOPMENTS 145
13.3.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 145
13.4 SHANGHAI FOSUN PHARMACEUTICAL(GROUP)CO., LTD. 146
13.4.1 COMPANY SNAPSHOT 146
13.4.2 SWOT ANALYSIS 147
13.4.3 REVENUE ANALYSIS 148
13.4.4 PRODUCT PORTFOLIO 148
13.4.5 RECENT DEVELOPMENTS 149
13.4.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 149
13.5 CYNOSURE 150
13.5.1 COMPANY SNAPSHOT 150
13.5.2 SWOT ANALYSIS 151
13.5.3 COMPANY SHARE ANALYSIS 152
13.5.4 PRODUCT PORTFOLIO 152
13.5.5 RECENT DEVELOPMENTS 154
13.5.6 DATA BRIDGE MARKET RESEARCH ANALYSIS 154
13.6 AEROLASE CORP. 155
13.6.1 COMPANY SNAPSHOT 155
13.6.2 PRODUCT PORTFOLIO 155
13.6.3 RECENT DEVELOPMENTS 155
13.7 A.R.C. LASER GMBH 156
13.7.1 COMPANY SNAPSHOT 156
13.7.2 PRODUCT PORTFOLIO 156
13.7.3 RECENT DEVELOPMENT 157
13.8 ASCLEPION LASER TECHNOLOGIES GMBH 158
13.8.1 COMPANY SNAPSHOT 158
13.8.2 PRODUCT PORTFOLIO 158
13.8.3 RECENT DEVELOPMENT 159
13.9 BTL 160
13.9.1 COMPANY SNAPSHOT 160
13.9.2 PRODUCT PORTFOLIO 160
13.9.3 RECENT DEVELOPMENTS 161
13.10 CUTERA 162
13.10.1 COMPANY SNAPSHOT 162
13.10.2 REVENUE ANALYSIS 162
13.10.3 COMPANY SHARE ANALYSIS 163
13.10.4 PRODUCT PORTFOLIO 163
13.10.5 RECENT DEVELOPMENTS 164
13.11 ECLIPSE 165
13.11.1 COMPANY SNAPSHOT 165
13.11.2 PRODUCT PORTFOLIO 165
13.11.3 RECENT DEVELOPMENTS 165
13.12 LUTRONIC 166
13.12.1 COMPANY SNAPSHOT 166
13.12.2 PRODUCT PORTFOLIO 166
13.12.3 RECENT DEVELOPMENTS 167
13.13 MENTOR WORLDWIDE LLC 168
13.13.1 COMPANY SNAPSHOT 168
13.13.2 REVENUE ANALYSIS 168
13.13.3 COMPANY SHARE ANALYSIS 169
13.13.4 PRODUCT PORTFOLIO 169
13.13.5 RECENT DEVELOPMENT 170
13.14 MERZ PHARMA 171
13.14.1 COMPANY SNAPSHOT 171
13.14.2 PRODUCT PORTFOLIO 171
13.14.3 RECENT DEVELOPMENTS 172
13.15 QUANTA SYSTEM 173
13.15.1 COMPANY SNAPSHOT 173
13.15.2 PRODUCT PORTFOLIO 173
13.15.3 RECENT DEVELOPMENTS 174
13.16 SCITON INC. 175
13.16.1 COMPANY SNAPSHOT 175
13.16.2 PRODUCT PORTFOLIO 175
13.16.3 RECENT DEVELOPMENTS 176
13.17 SHARPLIGHT TECHNOLOGIES INC 177
13.17.1 COMPANY SNAPSHOT 177
13.17.2 PRODUCT PORTFOLIO 177
13.17.3 RECENT DEVELOPMENT 178

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.